Peer - R Ev Iew D Peer - Reviewd Peer - Reviewd Peer - Reviewd Peer - Reviewd Peer - Reviewd

925. 45. Peacock-Villada E, Richardson BA, John-Stewart GC. Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries. Pediatrics. 2011;127:e423 41. 46. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477 89. 47. Leroy V, Malateste K, Rabie H, Lumbiganon P, Ayaya S, Dicko F, et al. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr. 2013;62:208 19. 48. McNairy ML, Lamb MR, Carter RJ, Fayorsey R, Tene G, Mutabazi V, et al. Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania. J Acquir Immune Defic Syndr. 2013;62:e70 81. 49. Sigaloff KC, Calis JC, Geelen SP, van Vugt M, de Wit TF. HIV-1-resistanceassociated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review. Lancet Infect Dis. 2011;11:769 79. 50. Barth RE, van der Loeff MF, Schuurman R, Hoepelman AI, Wensing AM. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2010;10: 155 66. 51. Meyers T, Sawry S, Wong JY, Moultrie H, Pinillos F, Fairlie L, et al. Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa. Pediatr Infect Dis J. 2015;34:175 9. 52. Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51:65 71. 53. Cluver L, Hodes R, Sherr L, Orkin MF, Meinck F, Lim ah Ken P, et al. Social protection: potential for improving HIV outcomes among adolescents. J Int AIDS Soc. 2015;18(Suppl 6):20299, doi: http://dx.doi.org/10.7448/IAS.18.7.20260 54. Lee S, Hazra R. Achieving 90-90-90 in pediatric HIV: adolescence as the touchstone for transition success. J Int AIDS Soc. 2015;18(Suppl 6):20257, doi: http://dx.doi.org/10.7448/IAS.18.7.20257 55. World Health Organization (2014). Fact sheet on adolescent health. [cited 2015 Sep 4]. Available from: http://www.unaids.org/en/media/unaids/ contentassets/documents/factsheet/2012/20120417_FS_adolescentsyoungpeoplehiv_en.pdf 56. World Health Organization (2014). Health for the world’s adolescents: a second chance in the second decade. [cited 2015 Sep 30]. Available from: http://www.who.int/maternal_child_adolescent/topics/adolescence/seconddecade/en/ 57. Fish R, Judd A, Jungmann E, O’Leary C, Foster C. Mortality in perinatally HIV-infected young people in England following transition to adult care: an HIV Young Persons Network (HYPNet) audit. HIV Med. 2014;15:239 44. Davies M-A and Pinto J. Journal of the International AIDS Society 2015, 18(Suppl 6):20745 http://www.jiasociety.org/index.php/jias/article/view/20745 | http://dx.doi.org/10.7448/IAS.18.7.20745